Q2 2018 Holdings
Filed 2018-08-13 | 54 holdings | $27.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $10.5M | 36,208 | 38.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $9.2M | 97,284 | 33.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $3.6M | 36,800 | 13.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $3.1M | 36,500 | 11.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $892.0K | 81,341 | 3.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $16.1K | 163,500 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $15.1K | 189,522 | 0.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $14.1K | 83,222 | 0.1% |
| Illumina Inc(ILMN) | COM | 452327109 | $12.6K | 45,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $11.6K | 694,500 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $10.8K | 31,330 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $10.1K | 81,641 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $9.6K | 444,534 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $9.6K | 370,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $8.4K | 125,975 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $7.9K | 492,930 | 0.0% |
| Ligand Pharmaceuticals Inc(LGND) | COM | 53220K504 | $7.3K | 35,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $7.2K | 428,633 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.7K | 42,996 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $6.4K | 90,284 | 0.0% |
| Spectrum Pharmaceuticals Inc | COM | 84763A108 | $6.3K | 300,000 | 0.0% |
| Abiomed Inc(ABMDEUR) | COM | 003654100 | $5.4K | 13,200 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $5.3K | 126,500 | 0.0% |
| Shire plc | SPONSORED ADR | 82481R106 | $4.2K | 25,000 | 0.0% |
| Intersect Ent Inc | COM | 46071F103 | $4.2K | 112,000 | 0.0% |
| Transenterix Inc | COM | 89366M201 | $3.8K | 889,082 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.6K | 27,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $3.4K | 500,000 | 0.0% |
| Bluebird Bio Inc | COM | 09609G100 | $3.1K | 20,000 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $3.1K | 72,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $3.0K | 77,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $2.8K | 42,500 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $2.8K | 16,200 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $2.8K | 10,000 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $2.7K | 46,300 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.6K | 322,436 | 0.0% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $2.0K | 31,400 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.9K | 145,000 | 0.0% |
| Merus N V | COM | N5749R100 | $1.7K | 75,060 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $1.6K | 113,000 | 0.0% |
| Globus Med Inc(GMED) | COM | 379577208 | $1.5K | 29,000 | 0.0% |
| GW Pharmaceuticals Plc | ADS | 36197T103 | $1.3K | 9,600 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $1.3K | 20,953 | 0.0% |
| Horizon Pharma Plc | SHS | G4617B105 | $1.1K | 69,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $1.1K | 103,500 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $1.0K | 370,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $998 | 14,779 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $992 | 12,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $915 | 58,600 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $906 | 24,000 | 0.0% |